Publications by authors named "Ryoma Moriya"

A 51-year-old man with advanced lung cancer underwent chemotherapy including an immune checkpoint inhibitor (ICI). Subsequently, he developed ICI-related pneumonitis and colitis, followed by a ten-month treatment course of high doses of steroids. An infection with the SARS-CoV-2 Omicron BA.

View Article and Find Full Text PDF

Introduction: Increasing numbers of cases of mild asymptomatic pulmonary alveolar proteinosis (PAP) are being reported with the recent increase in chest computed tomography (CT). Bronchoscopic diagnosis of mild PAP is challenging because of the patchy distribution of lesions, which makes it difficult to obtain sufficient biopsy samples. Additionally, the pathological findings of mild PAP, particularly those that differ from severe PAP, have not been fully elucidated.

View Article and Find Full Text PDF
Article Synopsis
  • Monoclonal antibody therapy showed effectiveness in preventing hospitalizations and severe COVID-19 cases, but identifying high-risk patients quickly is crucial due to limited drug availability.
  • A risk scoring system was developed to select at-risk patients during a COVID-19 surge in Japan, leading to treatment with REGN-CoV-2 starting August 2021.
  • Results indicated that administering the therapy resulted in significantly lower rates of hospitalization and severe cases, especially in younger patients, with only minor adverse events reported.
View Article and Find Full Text PDF

Nemaline myopathy (NM) is a rare muscle disease with various clinical types. In some cases, NM can lead to type 2 respiratory failure and right heart failure. We herein report a patient with congenital NM with nebulin gene mutation who presented with acute right heart failure and type 2 respiratory failure due to respiratory muscle paralysis after upper respiratory tract infection, needing a permanent ventilator for assistance.

View Article and Find Full Text PDF